BioVie Inc (NAS:BIVI)
$ 0.49 0.0264 (5.69%) Market Cap: 29.88 Mil Enterprise Value: 6.33 Mil PE Ratio: 0 PB Ratio: 1.58 GF Score: 30/100

BioVie Inc Conference Call Transcript

Nov 01, 2023 / 12:00PM GMT
Release Date Price: $4.6 (+5.50%)
Operator

Greetings and welcome to the BioVie conference call. (Operator Instructions)

As a reminder, this conference is being recorded. It is now my pleasure to introduce your host. Thank you, Cuong Do, you may begin.

Cuong Do
BioVie Inc. - President & CEO

Good morning, everyone, and thank you for joining us this morning for this conference call. My name is Cuong Do. I'm the President and CEO of BioVie. I am joined today by Dr. Joseph Palumbo, who is our Chief Medical Officer, and Dr. Steven Arnold of Harvard Medical School and Mass General Hospital.

Dr. Arnold was not involved in the trial that we will be discussing today, but Dr. Arnold is a member of our Scientific Advisory Board and has provided valuable advice and critique of what we do to help us get better, right?

So we are here today to discuss materials that we presented at CTAD last week, right? And as you know, the clinical trial in Alzheimer's disease is one of the leading conferences in this area. The data we presented there has been well received. And we wanted to have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot